A Medical Safety Officer is a key professional responsible for overseeing the comprehensive safety monitoring of therapeutic products throughout their entire lifecycle. Their primary focus is to collect, evaluate, and interpret safety data from multiple sources, such as clinical trials, post-marketing surveillance, healthcare providers, and scientific literature. By identifying and assessing adverse events, they ensure that potential risks are recognized early and managed effectively to protect patient health. These officers collaborate closely with cross-functional teams, including medical affairs, regulatory, and quality assurance, to update risk-benefit assessments and develop appropriate safety communications. Their work ensures ongoing compliance with global regulatory standards and supports the safe use of products worldwide.
Medical Safety Officers develop and maintain risk management strategies, including the preparation of comprehensive safety documents like Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs). They play an integral role in supporting regulatory submissions and responding to inquiries during audits and inspections. Training and educating internal teams on pharmacovigilance processes and adverse event reporting are also important responsibilities, fostering a culture of safety and vigilance. Staying current with changing regulations, guidelines, and industry best practices enables them to continuously improve safety monitoring systems. Through their diligent oversight and proactive approach, Medical Safety Officers contribute significantly to patient safety and the ongoing evaluation of therapeutic product safety profiles.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia